Read + Share
Amedeo Smart
Independent Medical Education
Holmberg D, Lagergren J. Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Dec 14. doi: 10.1007/s00535-022-01941.PMID: 36515731
Email
LinkedIn
Facebook
Twitter
Privacy Policy